| The effect of CYP2C19 polymorphism on the pharmacokinetics and pharmacodynamics of clopidogrel: a possible mechanism for clopidogrel resistance KA Kim, PW Park, SJ Hong, JY Park Clinical Pharmacology & Therapeutics 84 (2), 236-242, 2008 | 391 | 2008 |
| Effect of rifampin on the pharmacokinetics of rosiglitazone in healthy subjects JY Park, KA Kim, MH Kang, SL Kim, JG Shin Clinical Pharmacology & Therapeutics 75 (3), 157-162, 2004 | 198 | 2004 |
| Frequency of cytochrome P450 2C9 mutant alleles in a Korean population YR Yoon, JH Shon, MK Kim, YC Lim, HR Lee, JY Park, IJ Cha, JG Shin British journal of clinical pharmacology 51 (3), 277-280, 2001 | 188 | 2001 |
| Cytochrome P450 2C8 and CYP3A4/5 are involved in chloroquine metabolism in human liver microsomes KA Kim, JY Park, JS Lee, S Lim Archives of pharmacal research 26, 631-637, 2003 | 152 | 2003 |
| OPRM1 A118G Gene Variant and Postoperative Opioid Requirement: A Systematic Review and Meta-analysis IC Hwang, JY Park, SK Myung, HY Ahn, K Fukuda, Q Liao Anesthesiology 121 (4), 825-834, 2014 | 146 | 2014 |
| Effect of Polymorphic CYP3A5 Genotype on the Single‐Dose Simvastatin Pharmacokinetics in Healthy Subjects KA Kim, PW Park, OJ Lee, DK Kang, JY Park The Journal of Clinical Pharmacology 47 (1), 87-93, 2007 | 126 | 2007 |
| Effect of quercetin on the pharmacokinetics of rosiglitazone, a CYP2C8 substrate, in healthy subjects KA Kim, PW Park, HK Kim, JM Ha, JY Park The Journal of Clinical Pharmacology 45 (8), 941-946, 2005 | 118 | 2005 |
| Effects of CYP2C19 and CYP2C9 genetic polymorphisms on the disposition of and blood glucose lowering response to tolbutamide in humans JH Shon, YR Yoon, KA Kim, YC Lim, KJ Lee, JY Park, IJ Cha, ... Pharmacogenetics and Genomics 12 (2), 111-119, 2002 | 114 | 2002 |
| Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19 KS Yu, DS Yim, JY Cho, SS Park, JY Park, KH Lee, IJ Jang, SY Yi, KS Bae, ... Clinical Pharmacology & Therapeutics 69 (4), 266-273, 2001 | 107 | 2001 |
| Identification of cytochrome P450 isoforms involved in the metabolism of loperamide in human liver microsomes KA Kim, J Chung, DH Jung, JY Park European journal of clinical pharmacology 60, 575-581, 2004 | 100 | 2004 |
| Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects KA Kim, PW Park, OJ Lee, SH Choi, BH Min, KH Shin, BG Chun, JG Shin, ... Clinical Pharmacology & Therapeutics 80 (6), 646-656, 2006 | 93 | 2006 |
| Effect of ABCB1 (MDR1) haplotypes derived from G2677T/C3435T on the pharmacokinetics of amlodipine in healthy subjects KA Kim, PW Park, JY Park British journal of clinical pharmacology 63 (1), 53-58, 2007 | 91 | 2007 |
| Effect of CYP3A5*3 genotype on serum carbamazepine concentrations at steady‐state in Korean epileptic patients PW Park, YH Seo, JY Ahn, KA Kim, JY Park Journal of clinical pharmacy and therapeutics 34 (5), 569-574, 2009 | 89 | 2009 |
| Inhibitory effects of tricyclic antidepressants (TCAs) on human cytochrome P450 enzymes in vitro: mechanism of drug interaction between TCAs and phenytoin JG Shin, JY Park, MJ Kim, JH Shon, YR Yoon, IJ Cha, SS Lee, SW Oh, ... Drug metabolism and disposition 30 (10), 1102-1107, 2002 | 87 | 2002 |
| Enantioselective disposition of lansoprazole in extensive and poor metabolizers of CYP2C19 KA Kim, JH Shon, JY Park, YR Yoon, MJ Kim, DH Yun, MK Kim, IJ Cha, ... Clinical Pharmacology & Therapeutics 72 (1), 90-99, 2002 | 85 | 2002 |
| Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of alprazolam in healthy subjects JY Park, KA Kim, PW Park, OJ Lee, DK Kang, JH Shon, KH Liu, JG Shin Clinical Pharmacology & Therapeutics 79 (6), 590-599, 2006 | 84 | 2006 |
| Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes KA Kim, MJ Kim, JY Park, JH Shon, YR Yoon, SS Lee, KH Liu, JH Chun, ... Drug metabolism and disposition 31 (10), 1227-1234, 2003 | 84 | 2003 |
| Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers KA Kim, PW Park, JY Park European journal of clinical pharmacology 65, 609-614, 2009 | 79 | 2009 |
| Effect of rifampin on the pharmacokinetics and pharmacodynamics of gliclazide JY Park, KA Kim, PW Park, CW Park, JG Shin Clinical Pharmacology & Therapeutics 74 (4), 334-340, 2003 | 75 | 2003 |
| Assessment of CYP2C19 genetic polymorphisms in a korean population using a simultaneous multiplex pyrosequencing method to simultaneously detect the CYP2C19*2, CYP2C19*3 … KA Kim, WK Song, KR Kim, JY Park Journal of clinical pharmacy and therapeutics 35 (6), 697-703, 2010 | 70 | 2010 |
